The Society for Functional Precision Medicine
@TheSFPM
Followers
887
Following
462
Media
71
Statuses
669
Functional assays to improve patient outcomes. Join us: https://t.co/XoLE8MKHAv
Joined February 2018
RT @JoanMonte: 🚨 New Article Alert! Dive into a fantastic review by several @TheSFPM members on how new technologies and functional approa….
nature.com
Nature Reviews Cancer - Acquired therapeutic resistance is a key contributor to cancer treatment failure, requiring new approaches to address its complex mechanisms. In this Roadmap, Soragni,...
0
1
0
Join us *today* Wednesday 03/12 @ 12:00 PM EST for our monthly SFPM seminar! Dr. Perova from @emblebi will discuss: "Leveraging enhancing precision oncology through collaborative cancer model resources".
sfpm.io
The SFPM Seminar series is for those interested in the use of assaying technology to further biomarker discovery, drug R&D and personalized healthcare outcomes.
0
0
0
RT @oncodaily: Exploring high-throughput drug sensitivity testing in neuroblastoma cell lines - Karin Langenberg-Ververgaert.@TheSFPM @prin….
0
1
0
Join us *today* Wednesday 02/12 @ 12:00 PM EST for our monthly SFPM seminar!. Dr. Andrew Satterlee from @UNC will discuss overcoming systemic barriers to functional precision medicine using a versatile ex vivo model of patient brain tumors.
1
0
0
An exciting multicenter phase 2 functional precision medicine clinical trial showing how a rapid ex vivo venetoclax sensitivity assay was the strongest predictor for a favorable treatment response and survival in relapsed/refractory secondary AML.
ashpublications.org
Key PointsBlast-specific ex vivo venetoclax sensitivity correlated strongly with treatment responses and predicted longer survival.VenEx trial showed that
4
1
1
Join us *tomorrow* Wednesday 12/11 @ 12:00 PM EST for our last monthly SFPM seminar of the year!. Drs. Damle and Pillarisetty from @fredhutch will discuss tumor slice cultures as a window into the human TME. Info to join here:
sfpm.io
The SFPM Seminar series is for those interested in the use of assaying technology to further biomarker discovery, drug R&D and personalized healthcare outcomes.
0
0
0
🚨NEW study from our LAB showing the predictive value of Patient-derived Breast Cancer 🐟zebrafish Avatars ! A co-clinical study where we compare the patient clinical response to treatment with their matching 🐟zAvatar! ✨100% @ChampalimaudF @TheSFPM.
0
1
4
Mark your calendars for the next Functional Precision Medicine meeting (March 11-13, 2025)! .Submit your abstract by November 15th.#FPM.
Submit an abstract by November 15 for the AACR Special Conference on Functional and Genomic Precision Medicine in Cancer (March 11-13, Boston), chaired by Anthony Letai, Elaine Mardis, Peter Horak, and Alice Soragni. #AACRprecmed25 @DrTonyLetai @soragnilab
0
1
3
RT @JoanMonte: What an inspiring week at the EHA-SFPM Congress in Copenhagen! Thank you to all the researchers, clinicians, and innovators….
0
6
0
Let's all get functional! A functional precision medicine perspective on sarcoma from Dr. @StefanFrohling and Dr. Claudia Ball from @DKFZ #FPM.
Let’s get functional: Drug sensitivity profiling to enable precision sarcoma medicine
0
1
4
RT @ALadungova: 📍Had an inspiring time at the @EHA_Hematology &.@TheSFPM Conference in Copenhagen. 💡The take-home message was how to make….
0
4
0
Olli Kallioniemi is our last keynote speaker, discussing technology and precision medicine in the AI era. Very thoughtful considerations on how more data does not necessarily translate into more clinical benefits. When is data “enough”? #FPM
0
0
3
Our president @DrTonyLetai reminding all to join the @TheSFPM as we approach the conclusion of a very exciting and successful EHA-SFPM meeting in Copenhagen
0
5
11
Dr. McWeeney addressing AI Regulatory complexities and upcoming challenges as recognized by the FDA
1
0
1
A perspective on leveraging AI to address critical challenges in precision medicine and bridging functional and genetic evidence by @WonderMixTape on the last day of the EHA-SfPM meeting in Copenhagen #FPM
1
2
4